Lululemon: Cutting Pounds, Crafting Profits

Justin Sullivan Investment Thesis In this article, I explore how GLP-1 weight-loss drugs, from Eli Lilly and Company (LLY) and Novo Nordisk A/S (NVO), have impacted people. While briefly discussing the significance of these drugs in the obesity management field, I will mainly dive into their influence on the apparel industry. I think Lululemon Athletica Inc. (NASDAQ:LULU) will benefit greatly as people losing weight will see a need to purchase new, fitting attire. And there is notable data that emphasizes t ...